Versant Venture Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Hold |
|
|||||
|
2025
Q1 | $17M | Hold |
|
|||||
|
2024
Q4 | $19.6M | Hold |
|
|||||
|
2024
Q3 | $23.4M | Hold |
|
|||||
|
2024
Q2 | $26.9M | Hold |
|
|||||
|
2024
Q1 | $34M | Hold |
|
|||||
|
2023
Q4 | $31.2M | Hold |
|
|||||
|
2023
Q3 | $22.6M | Hold |
|
|||||
|
2023
Q2 | $28M | Hold |
|
|||||
|
2023
Q1 | $22.5M | Hold |
|
|||||
|
2022
Q4 | $20.3M | Hold |
|
|||||
|
2022
Q3 | $32.6M | Hold |
|
|||||
|
2022
Q2 | $30.3M | Hold |
|
|||||
|
2022
Q1 | $31.3M | Hold |
|
|||||
|
2021
Q4 | $37.8M | Hold |
|
|||||
|
2021
Q3 | $55.8M | Sell |
|
|||||
|
2021
Q2 | $82.3M | Sell |
|
|||||
|
2021
Q1 | $189M | Sell |
|
|||||
|
2020
Q4 | $466M | Sell |
|
|||||
|
2020
Q3 | $304M | Sell |
|
|||||
|
2020
Q2 | $307M | Sell |
|
|||||
|
2020
Q1 | $177M | Hold |
|
|||||
|
2019
Q4 | $256M | Sell |
|
|||||
|
2019
Q3 | $174M | Sell |
|
|||||
|
2019
Q2 | $200M | Hold |
|
|||||
|
2019
Q1 | $152M | Buy |
|
|||||
|
2018
Q4 | $103M | Hold |
|
|||||
|
2018
Q3 | $160M | Hold |
|
|||||
|
2018
Q2 | $212M | Sell |
|
|||||
|
2018
Q1 | $211M | Buy |
|